Human urinary kallidinogenase decreases the incidence of post-stroke cognitive impairment in acute ischemic stroke patients
Background: Post-stroke cognitive impairment (PSCI) is a common symptom of stroke and affects the quality of life and prognosis of stroke survivors. In our study, we evaluated the efficacy of Human urinary kallidinogenase (HUK) on cognitive function in acute ischemic stroke (AIS) patients, and discu...
| Main Authors: | Xu Yan, Huan Chen, Xiuli Shang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2022-04-01
|
| Series: | Journal of Integrative Neuroscience |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/JIN/21/3/10.31083/j.jin2103080 |
Similar Items
-
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
by: Yun Qian, et al.
Published: (2019-12-01) -
Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis
by: Di‐Xiao Yang, et al.
Published: (2021-12-01) -
Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
by: Zhenyu Wei, et al.
Published: (2018-06-01) -
Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke
by: Juexian Song, et al.
Published: (2018-02-01) -
Cost-effectiveness of edaravone dexborneol versus human urinary kallidinogenase for acute ischemic stroke in China
by: Pingyu Chen, et al.
Published: (2024-01-01)